RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating Cells

Cancer Cell

Volumn 30, Issue 1, 2016, Pages 75-91

  Höckendorf, Ulrike ^a   Yabal, Monica ^a   Herold, Tobias ^b   Munkhbaatar, Enkhtsetseg ^a   Rott, Stephanie ^a   Jilg, Stefanie ^a   Kauschinger, Johanna ^a   Magnani, Giovanni ^c   Reisinger, Florian ^d   Heuser, Michael ^e   Kreipe, Hans ^e   Sotlar, Karl ^f   Engleitner, Thomas ^a,g   Rad, Roland ^a,g   Weichert, Wilko ^a,g   Peschel, Christian ^a,g   Ruland, Jürgen ^c,g   Heikenwalder, Mathias ^d,g   Spiekermann, Karsten ^b,g   Slotta Huspenina, Julia ^a   Groß, Olaf ^c   Jost, Philipp J ^a,g   more..

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f UNIVERSITY OF MUNICH   (Germany)

^g GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INFLAMMASOME; INTERLEUKIN 1BETA; MIXED LINEAGE KINASE; PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN KINASE 3; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK3 PROTEIN, HUMAN; RIPK3 PROTEIN, MOUSE;

ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PATIENT; CELL DEATH; CELL DIFFERENTIATION; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE RELEASE; GENE; GENE LOSS; HEMATOPOIETIC CELL; HUMAN; HUMAN TISSUE; LEUKEMIA CELL; LEUKEMIC INITIATING CELL; LEUKEMOGENESIS; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PRIORITY JOURNAL; RIPK3 GENE; SIGNAL TRANSDUCTION; ACUTE MYELOID LEUKEMIA; ANIMAL; APOPTOSIS; CANCER STEM CELL; CYTOLOGY; DOWN REGULATION; EXPERIMENTAL NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PROCEDURES; TUMOR CELL CULTURE;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; INFLAMMASOMES; LEUKEMIA, MYELOID, ACUTE; MICE; NEOPLASMS, EXPERIMENTAL; NEOPLASTIC STEM CELLS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR CELLS, CULTURED;

EID: 84979732790     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2016.06.002     Document Type: Article

References (44)

1. Bertrand, M.J., Milutinovic, S., Dickson, K.M., Ho, W.C., Boudreault, A., Durkin, J., Gillard, J.W., Jaquith, J.B., Morris, S.J., Barker, P.A., cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 30 (2008), 689–700.
2. Cai, Z., Jitkaew, S., Zhao, J., Chiang, H.C., Choksi, S., Liu, J., Ward, Y., Wu, L.G., Liu, Z.G., Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat. Cell Biol. 16 (2014), 55–65.
3. Cancer Genome Atlas Research Network, Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 368 (2013), 2059–2074.
4. Cauchy, P., James, S.R., Zacarias-Cabeza, J., Ptasinska, A., Imperato, M.R., Assi, S.A., Piper, J., Canestraro, M., Hoogenkamp, M., Raghavan, M., et al. Chronic FLT3-ITD signaling in acute myeloid leukemia is connected to a specific chromatin signature. Cell Rep. 12 (2015), 821–836.
5. Cho, Y., Challa, S., Moquin, D., Genga, R., Ray, T.D., Guildford, M., Chan, F.K.-M., Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137 (2009), 1112–1123.
6. Chu, S.H., Heiser, D., Li, L., Kaplan, I., Collector, M., Huso, D., Sharkis, S.J., Civin, C., Small, D., FLT3-ITD knockin impairs hematopoietic stem cell quiescence/homeostasis, leading to myeloproliferative neoplasm. Cell Stem Cell 11 (2012), 346–358.
7. Duprez, L., Takahashi, N., Van Hauwermeiren, F., Vandendriessche, B., Goossens, V., Vanden Berghe, T., Declercq, W., Libert, C., Cauwels, A., Vandenabeele, P., RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity 35 (2011), 908–918.
8. Glaccum, M.B., Stocking, K.L., Charrier, K., Smith, J.L., Willis, C.R., Maliszewski, C., Livingston, D.J., Peschon, J.J., Morrissey, P.J., Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J. Immunol. 159 (1997), 3364–3371.
9. Herold, T., Metzeler, K.H., Vosberg, S., Hartmann, L., Rollig, C., Stolzel, F., Schneider, S., Hubmann, M., Zellmeier, E., Ksienzyk, B., et al. Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis. Blood 124 (2014), 1304–1311.
10. Huntly, B.J., Gilliland, D.G., Leukaemia stem cells and the evolution of cancer-stem-cell research. Nat. Rev. Cancer 5 (2005), 311–321.
11. Jacobsen, S.E., Ruscetti, F.W., Okkenhaug, C., Lien, E., Ortiz, M., Veiby, O.P., Keller, J.R., Distinct and direct synergistic effects of IL-1 and IL-6 on proliferation and differentiation of primitive murine hematopoietic progenitor cells in vitro. Exp. Hematol. 22 (1994), 1064–1069.
12. Jilg, S., Reidel, V., Muller-Thomas, C., Konig, J., Schauwecker, J., Hockendorf, U., Huberle, C., Gorka, O., Schmidt, B., Burgkart, R., et al. Blockade of BCL-2 proteins efficiently induces apoptosis in progenitor cells of high-risk myelodysplastic syndromes patients. Leukemia 30 (2016), 112–123.
13. Kang, S., Fernandes-Alnemri, T., Rogers, C., Mayes, L., Wang, Y., Dillon, C., Roback, L., Kaiser, W., Oberst, A., Sagara, J., et al. Caspase-8 scaffolding function and MLKL regulate NLRP3 inflammasome activation downstream of TLR3. Nat. Commun., 6, 2015, 7515.
14. Kelly, L.M., Liu, Q., Kutok, J.L., Williams, I.R., Boulton, C.L., Gilliland, D.G., FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model. Blood 99 (2002), 310–318.
15. Lawlor, K.E., Khan, N., Mildenhall, A., Gerlic, M., Croker, B.A., D'Cruz, A.A., Hall, C., Kaur Spall, S., Anderton, H., Masters, S.L., et al. RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL. Nat. Commun., 6, 2015, 6282.
16. Mandal, P., Berger, S.B., Pillay, S., Moriwaki, K., Huang, C., Guo, H., Lich, J.D., Finger, J., Kasparcova, V., Votta, B., et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol. Cell 56 (2014), 481–495.
17. Marcucci, G., Radmacher, M.D., Maharry, K., Mrózek, K., Ruppert, A.S., Paschka, P., Vukosavljevic, T., Whitman, S.P., Baldus, C.D., Langer, C., et al. MicroRNA expression in cytogenetically normal acute myeloid leukemia. N. Engl. J. Med. 358 (2008), 1919–1928.
18. Mariathasan, S., Newton, K., Monack, D.M., Vucic, D., French, D.M., Lee, W.P., Roose-Girma, M., Erickson, S., Dixit, V.M., Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430 (2004), 213–218.
19. Mead, A.J., Kharazi, S., Atkinson, D., Macaulay, I., Pecquet, C., Loughran, S., Lutteropp, M., Woll, P., Chowdhury, O., Luc, S., et al. FLT3-ITDs instruct a myeloid differentiation and transformation bias in lymphomyeloid multipotent progenitors. Cell Rep. 3 (2013), 1766–1776.
20. Murphy, J.M., Czabotar, P.E., Hildebrand, J.M., Lucet, I.S., Zhang, J.G., Alvarez-Diaz, S., Lewis, R., Lalaoui, N., Metcalf, D., Webb, A.I., et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 39 (2013), 443–453.
21. Newton, K., Sun, X., Dixit, V.M., Kinase RIP3 is dispensable for normal NF- Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and toll-like receptors 2 and 4. Mol. Cell Biol. 24 (2004), 1464–1469.
22. Nugues, A.L., El Bouazzati, H., Hetuin, D., Berthon, C., Loyens, A., Bertrand, E., Jouy, N., Idziorek, T., Quesnel, B., RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65/RelA cleavage. Cell Death Dis., 5, 2014, e1384.
23. Onizawa, M., Oshima, S., Schulze-Topphoff, U., Oses-Prieto, J.A., Lu, T., Tavares, R., Prodhomme, T., Duong, B., Whang, M.I., Advincula, R., et al. The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis. Nat. Immunol. 16 (2015), 618–627.
24. Pasparakis, M., Vandenabeele, P., Necroptosis and its role in inflammation. Nature 517 (2015), 311–320.
25. Peschon, J.J., Torrance, D.S., Stocking, K.L., Glaccum, M.B., Otten, C., Willis, C.R., Charrier, K., Morrissey, P.J., Ware, C.B., Mohler, K.M., TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 160 (1998), 943–952.
26. Pronk, C.J., Veiby, O.P., Bryder, D., Jacobsen, S.E., Tumor necrosis factor restricts hematopoietic stem cell activity in mice: involvement of two distinct receptors. J. Exp. Med. 208 (2011), 1563–1570.
27. Rickard, J.A., O'Donnell, J.A., Evans, J.M., Lalaoui, N., Poh, A.R., Rogers, T., Vince, J.E., Lawlor, K.E., Ninnis, R.L., Anderton, H., et al. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 157 (2014), 1175–1188.
28. Schenk, T., Chen, W.C., Gollner, S., Howell, L., Jin, L., Hebestreit, K., Klein, H.U., Popescu, A.C., Burnett, A., Mills, K., et al. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia. Nat. Med. 18 (2012), 605–611.
29. Schroder, K., Tschopp, J., The inflammasomes. Cell 140 (2010), 821–832.
30. Shlush, L.I., Zandi, S., Mitchell, A., Chen, W.C., Brandwein, J.M., Gupta, V., Kennedy, J.A., Schimmer, A.D., Schuh, A.C., Yee, K.W., et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature 506 (2014), 328–333.
31. Su, R., Lin, H.S., Zhang, X.H., Yin, X.L., Ning, H.M., Liu, B., Zhai, P.F., Gong, J.N., Shen, C., Song, L., et al. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets. Oncogene 34 (2015), 3226–3239.
32. Takizawa, H., Boettcher, S., Manz, M.G., Demand-adapted regulation of early hematopoiesis in infection and inflammation. Blood 119 (2012), 2991–3002.
33. Tenen, D.G., Disruption of differentiation in human cancer: AML shows the way. Nat. Rev. Cancer 3 (2003), 89–101.
34. Vassiliou, G.S., Cooper, J.L., Rad, R., Li, J., Rice, S., Uren, A., Rad, L., Ellis, P., Andrews, R., Banerjee, R., et al. Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice. Nat. Genet. 43 (2011), 470–475.
35. Verhaak, R.G., Wouters, B.J., Erpelinck, C.A., Abbas, S., Beverloo, H.B., Lugthart, S., Lowenberg, B., Delwel, R., Valk, P.J., Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling. Haematologica 94 (2009), 131–134.
36. Vo, T.T., Ryan, J., Carrasco, R., Neuberg, D., Rossi, D.J., Stone, R.M., Deangelo, D.J., Frattini, M.G., Letai, A., Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML. Cell 151 (2012), 344–355.
37. Volk, A., Li, J., Xin, J., You, D., Zhang, J., Liu, X., Xiao, Y., Breslin, P., Li, Z., Wei, W., et al. Co-inhibition of NF-kappaB and JNK is synergistic in TNF-expressing human AML. J. Exp. Med. 211 (2014), 1093–1108.
38. Wang, H., Sun, L., Su, L., Rizo, J., Liu, L., Wang, L.F., Wang, F.S., Wang, X., Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol. Cell 54 (2014), 133–146.
39. Welch, J.S., Ley, T.J., Link, D.C., Miller, C.A., Larson, D.E., Koboldt, D.C., Wartman, L.D., Lamprecht, T.L., Liu, F., Xia, J., et al. The origin and evolution of mutations in acute myeloid leukemia. Cell 150 (2012), 264–278.
40. Wong, W.W., Vince, J.E., Lalaoui, N., Lawlor, K.E., Chau, D., Bankovacki, A., Anderton, H., Metcalf, D., O'Reilly, L., Jost, P.J., et al. cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner. Blood 123 (2014), 2562–2572.
41. Yabal, M., Muller, N., Adler, H., Knies, N., Gross, C.J., Damgaard, R.B., Kanegane, H., Ringelhan, M., Kaufmann, T., Heikenwalder, M., et al. XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation. Cell Rep. 7 (2014), 1796–1808.
42. Yan, M., Kanbe, E., Peterson, L.F., Boyapati, A., Miao, Y., Wang, Y., Chen, I.M., Chen, Z., Rowley, J.D., Willman, C.L., Zhang, D.E., A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Nat. Med. 12 (2006), 945–949.
43. Yang, J., Ikezoe, T., Nishioka, C., Nobumoto, A., Yokoyama, A., IL-1beta inhibits self-renewal capacity of dormant CD34(+)/CD38(-) acute myelogenous leukemia cells in vitro and in vivo. Int. J. Cancer 133 (2013), 1967–1981.
44. Zhao, J.L., Ma, C., O'Connell, R.M., Mehta, A., DiLoreto, R., Heath, J.R., Baltimore, D., Conversion of danger signals into cytokine signals by hematopoietic stem and progenitor cells for regulation of stress-induced hematopoiesis. Cell Stem Cell 14 (2014), 445–459.